{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:08:55Z","timestamp":1783901335265,"version":"3.55.0"},"reference-count":13,"publisher":"Walter de Gruyter GmbH","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hemolytic disease of the fetus and newborn (HDFN) due to an antibody in the Kell blood group system can be associated with severe fetal anemia. This case report details the challenges of managing a Kell\n                    <jats:sub>null<\/jats:sub>\n                    mother with anti-Ku that affected her fetus\/newborn. A gravida 4 para 3 woman at term underwent an emergency lower caesarean section because of fetal distress. The baby was intubated because of low oxygen saturation. An urgent request for a hematology workup showed severe anemia and erythroblastosis fetalis. Unfortunately, no compatible blood was found, and the baby died. The case was referred to the National Blood Centre, and anti-Ku was confirmed in a sample sent from the mother. When she presented with her fifth pregnancy, meticulous planning was used to manage this pregnancy. Her family screening revealed one brother with a matching phenotype. Three blood donations were planned for the brother\u2014for freezing, for intrauterine transfusion, and for standby during delivery. Serial anti-Ku titrations of maternal samples were performed, and the fetus was monitored for anemia through middle cerebral artery Doppler scans. Although the anti-Ku titers reached as high as 1024, fetal anemia was never diagnosed. The neonate was delivered safely but was diagnosed with severe pathologic jaundice and anemia secondary to HDFN and congenital pneumonia. The baby was transfused with K\n                    <jats:sub>0<\/jats:sub>\n                    packed red blood cells and later discharged to home.\n                  <\/jats:p>","DOI":"10.2478\/immunohematology-2024-016","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T05:37:56Z","timestamp":1728279476000},"page":"122-127","source":"Crossref","is-referenced-by-count":2,"title":["A challenging case of hemolytic disease of the fetus and newborn (HDFN) due to anti-Ku in a K\n                    <sub>0<\/sub>\n                    (Kell\n                    <sub>null<\/sub>\n                    ) mother"],"prefix":"10.2478","volume":"40","author":[{"given":"Siti A.","family":"Wan Mohd Hasni","sequence":"first","affiliation":[{"name":"National Immunohematology Reference Laboratory , National Blood Centre , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nor H.","family":"Ahmad","sequence":"additional","affiliation":[{"name":"National Immunohematology Reference Laboratory , National Blood Centre , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muniswaran","family":"Ganeshan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology , Hospital Tunku Azizah , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon L.","family":"Yong","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology , Hospital Tunku Azizah , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei P.","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Pathology , Hospital Sultan Haji Ahmad Shah , Pahang , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahimah Abdul","family":"Wahab","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine , Hospital Raja Perempuan Zainab II, Jalan Hospital , Kelantan , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozi H.","family":"Musa","sequence":"additional","affiliation":[{"name":"National Immunohematology Reference Laboratory , National Blood Centre , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunaseelan","family":"Muniandi","sequence":"additional","affiliation":[{"name":"National Immunohematology Reference Laboratory , National Blood Centre , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambika","family":"Nakulan","sequence":"additional","affiliation":[{"name":"National Immunohematology Reference Laboratory , National Blood Centre , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afifah","family":"Hassan","sequence":"additional","affiliation":[{"name":"Laboratory and Blood Services Department , National Heart Institute , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"key":"2026071214320112157_j_immunohematology-2024-016_ref_001","doi-asserted-by":"crossref","unstructured":"Ohto H, Denomme GA, Ito S, Ishida A, Nollet KE, Yasuda H. Three non-classical mechanisms for anemic disease of the fetus and newborn, based on maternal anti-Kell, anti-Ge3, anti-M, and anti-Jra cases. Transfus Aphers Sci 2020;59:102949. doi: 10.1016\/j.transci.2020.102949.","DOI":"10.1016\/j.transci.2020.102949"},{"key":"2026071214320112157_j_immunohematology-2024-016_ref_002","doi-asserted-by":"crossref","unstructured":"Zwiers C, Oepkes D, Lopriore E, Klumper FJ, de Haas M, van Kamp IL. The near disappearance of fetal hydrops in relation to current state-of-the-art management of red cell alloimmunization. Prenat Diagn 2018;38:943\u201350. doi: 10.1002\/pd.5355.","DOI":"10.1002\/pd.5355"},{"key":"2026071214320112157_j_immunohematology-2024-016_ref_003","doi-asserted-by":"crossref","unstructured":"Kakaiya RM, Whaley A, Howard-Menk C, et al. Absence of hemolytic disease of fetus and newborn despite maternal high-titer IgG anti-Ku. Immunohematology 2010;26:119\u201323.","DOI":"10.21307\/immunohematology-2019-211"},{"key":"2026071214320112157_j_immunohematology-2024-016_ref_004","doi-asserted-by":"crossref","unstructured":"Vaughan JI, Manning M, Warwick RM, Letsky EA, Murray NA, Roberts IA. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998;338:798\u2013803. doi: 10.1056\/NEJM199803193381204.","DOI":"10.1056\/NEJM199803193381204"},{"key":"2026071214320112157_j_immunohematology-2024-016_ref_005","doi-asserted-by":"crossref","unstructured":"Brennand J. Middle cerebral ar tery Doppler. Australas J Ultrasound Med 2009;12:35\u20138. doi: 10.1002\/j.2205-0140.2009.tb00058.x.","DOI":"10.1002\/j.2205-0140.2009.tb00058.x"},{"key":"2026071214320112157_j_immunohematology-2024-016_ref_006","doi-asserted-by":"crossref","unstructured":"Myle AK, Al-Khattabi GH. Hemolytic disease of the newborn: a review of current trends and prospects. Pediatric Health Med Ther 2021;12:491\u20138. doi: 10.2147\/PHMT.S327032.","DOI":"10.2147\/PHMT.S327032"},{"key":"2026071214320112157_j_immunohematology-2024-016_ref_007","doi-asserted-by":"crossref","unstructured":"Koelewijn JM, de Haas M, Vrijkotte TG, et al. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy. Transfusion 2008;48:1721\u20139.","DOI":"10.1111\/j.1537-2995.2008.01742.x"},{"key":"2026071214320112157_j_immunohematology-2024-016_ref_008","doi-asserted-by":"crossref","unstructured":"de Haas M, Thurik FF, Koelewijn JM, van der Schoot CE. Haemolytic disease of the fetus and newborn. Vox Sang 2015;109:99\u2013113. doi: 10.1111\/vox.12265.","DOI":"10.1111\/vox.12265"},{"key":"2026071214320112157_j_immunohematology-2024-016_ref_009","unstructured":"Harmening DM. Modern blood banking and transfusion practices. 7th ed. Philadelphia: FA Davis, 2019."},{"key":"2026071214320112157_j_immunohematology-2024-016_ref_010","doi-asserted-by":"crossref","unstructured":"Franklin IM. Prevention of rhesus haemolytic disease of the fetus and newborn. Lancet 2009;373:1082. doi: 10.1016\/S0140-6736(09)60651-6.","DOI":"10.1016\/S0140-6736(09)60651-6"},{"key":"2026071214320112157_j_immunohematology-2024-016_ref_011","doi-asserted-by":"crossref","unstructured":"Caine ME, Mueller-Heubach E. Kell sensitization in pregnancy. Am J Obstet Gynecol 1986;154:85\u201390. doi: 10.1016\/0002-9378(86)90398-4.","DOI":"10.1016\/0002-9378(86)90398-4"},{"key":"2026071214320112157_j_immunohematology-2024-016_ref_012","doi-asserted-by":"crossref","unstructured":"Vaughan JI, Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NM. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994;171:247\u201352. doi: 10.1016\/0002-9378(94)90477-4.","DOI":"10.1016\/0002-9378(94)90477-4"},{"key":"2026071214320112157_j_immunohematology-2024-016_ref_013","doi-asserted-by":"crossref","unstructured":"Lydaki E, Nikoloudi I, Kaminopetros P, et al. Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku. Transfusion 2005;45:1791\u20135. doi: 10.1111\/j.1537-2995.2005.00604.x.","DOI":"10.1111\/j.1537-2995.2005.00604.x"}],"container-title":["Immunohematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/immunohematology-2024-016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T23:33:44Z","timestamp":1783899224000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/immunohematology-2024-016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":13,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,10,4]]},"published-print":{"date-parts":[[2024,9,1]]}},"alternative-id":["10.2478\/immunohematology-2024-016"],"URL":"https:\/\/doi.org\/10.2478\/immunohematology-2024-016","relation":{},"ISSN":["1930-3955"],"issn-type":[{"value":"1930-3955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,1]]}}}